RCE Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Recce Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Recce Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Recce Pharmaceuticals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/12/2020 01:00 AM ET

This chart shows the closing price history over time for RCE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Recce Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2022Alistair McKeoughInsiderIssued1,125,000A$0.28A$312,750.00
6/21/2021Michele DiliziaInsiderSell175,000A$1.02A$178,325.00
6/16/2021James GrahamInsiderBuy47,850A$1.05A$50,003.25
7/9/2020James GrahamInsiderBuy389,712A$1.05A$409,197.60
See Full Table
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
[Full Story]

SEC Filings (Institutional Ownership Changes) for Recce Pharmaceuticals (ASX:RCE)

Recce Pharmaceuticals logo
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti-infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.
Read More on Recce Pharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

630,087 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Recce Pharmaceuticals?

Recce Pharmaceuticals' top insider investors include:
  1. Alistair McKeough (Insider)
  2. James Graham (Insider)
  3. Michele Dilizia (Insider)
Learn More about top insider investors at Recce Pharmaceuticals.